Advertisement
U.S. markets closed

MediPharm Labs Corp. (MEDIF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0632+0.0010 (+1.61%)
At close: 03:25PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0622
Open0.0540
BidN/A x N/A
AskN/A x N/A
Day's Range0.0540 - 0.0668
52 Week Range0.0400 - 0.0770
Volume320,583
Avg. Volume119,160
Market Cap27.018M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings DateMar 27, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MEDIF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MEDIPHARM LABS CORP
    IIPR: Raising target price to $109.00INNOVATIVE INDUSTRIAL PROPER has an Investment Rating of HOLD; a target price of $109.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more